SEGMENT REPORTING - Schedule of Operating Financial Results of Therapeutics Segment (Details) - USD ($) $ in Thousands |
3 Months Ended | 6 Months Ended | ||||
|---|---|---|---|---|---|---|
Jun. 30, 2025 |
Mar. 31, 2025 |
Jun. 30, 2024 |
Mar. 31, 2024 |
Jun. 30, 2025 |
Jun. 30, 2024 |
|
| Revenues: | ||||||
| Total revenues | $ 102,660 | $ 40,813 | $ 180,995 | $ 68,427 | ||
| Operating expenses: | ||||||
| Research and development | 15,594 | 12,319 | 30,003 | 24,385 | ||
| General and administrative | 103,013 | 58,792 | 188,008 | 110,370 | ||
| Total operating expenses | 124,844 | 74,115 | 229,459 | 139,413 | ||
| Loss from operations before other income (expense) | (22,184) | (33,302) | (48,464) | (70,986) | ||
| Net loss | (20,340) | $ (25,120) | (33,290) | $ (35,731) | (45,460) | (69,021) |
| Other segment disclosures: | ||||||
| Interest income | 4,229 | 4,130 | 7,683 | 7,247 | ||
| Interest expense | (2,240) | (2,109) | (4,453) | (3,092) | ||
| Reportable Segment | ||||||
| Revenues: | ||||||
| Total revenues | 102,660 | 40,813 | 180,995 | 68,427 | ||
| Operating expenses: | ||||||
| Cost of sales | 6,237 | 3,004 | 11,448 | 4,658 | ||
| Research and development | 15,594 | 12,319 | 30,003 | 24,385 | ||
| Selling and marketing | 65,857 | 32,251 | 126,143 | 60,138 | ||
| General and administrative | 37,156 | 26,541 | 61,865 | 50,232 | ||
| Total operating expenses | 124,844 | 74,115 | 229,459 | 139,413 | ||
| Loss from operations before other income (expense) | (22,184) | (33,302) | (48,464) | (70,986) | ||
| Other reconciling items | 1,844 | 12 | 3,004 | 1,965 | ||
| Net loss | (20,340) | (33,290) | (45,460) | (69,021) | ||
| Other segment disclosures: | ||||||
| Interest income | 4,229 | 4,130 | 7,683 | 7,247 | ||
| Interest expense | (2,240) | (2,109) | (4,453) | (3,092) | ||
| Depreciation and amortization expense | 453 | 239 | 913 | 509 | ||
| Product sales, net | ||||||
| Revenues: | ||||||
| Total revenues | 102,660 | 40,813 | 180,995 | 65,533 | ||
| Operating expenses: | ||||||
| Cost of sales | 6,237 | 3,004 | 11,448 | 4,658 | ||
| Product sales, net | Reportable Segment | ||||||
| Revenues: | ||||||
| Total revenues | 102,660 | 40,813 | 180,995 | 65,533 | ||
| License fees and collaboration revenue | ||||||
| Revenues: | ||||||
| Total revenues | 0 | 0 | 0 | 2,894 | ||
| License fees and collaboration revenue | Reportable Segment | ||||||
| Revenues: | ||||||
| Total revenues | $ 0 | $ 0 | $ 0 | $ 2,894 | ||
| X | ||||||||||
- Definition The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Total costs of sales and operating expenses for the period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of interest expense classified as nonoperating. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of interest income earned from interest bearing assets classified as other. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The net result for the period of deducting operating expenses from operating revenues. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss). Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Amount of other expense (income) and loss (gain) calculated as difference between segment revenue and separately disclosed expense category to arrive at segment profit (loss). Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition The aggregate total amount of expenses directly related to the marketing or selling of products or services. No definition available.
|
| X | ||||||||||
- Definition The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|